諾瓦瓦克斯醫藥 NVAX 深 滬
已收盤 07-02 16:00:00 美东时间
9.74
+0.280
+2.96%
華盛通- 最 高10.115
- 今 開9.558
- 成交量 484.95万股
- 最 低 9.452
- 昨 收 9.46
- 總市值 16.02亿
- 52周最高 11.97
- 市盈率 靜 3.83
- 換手率 2.95%
- 52周最低 6.20
- 委 比 -74.60%
- 總股本 1.64亿
- 歷史最高 331.68
- 量 比 0.96
- 振 幅 7.01%
- 歷史最低 3.5324
- 每 手 1
- 風險率 1.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in June 2026
Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like Rec...
07-01 22:20
RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs
HHS Secretary Robert F. Kennedy Jr. has terminated Emergency Use Authorizations for drugs and medical devices to treat COVID-19. The EUAs for drugs and biologics will end in 12 months and in 180 days ...
07-01 02:30
Novavax faces renewed attack by Shah Capital after AGM
Shah Capital, the largest shareholder of Novavax (NVAX), criticized the company’s leadership on Wednesday, even after the COVID-19 vaccine developer managed to get shareholder backing for all resoluti...
06-24 20:43
投资者密集搜索诺瓦瓦克斯医药（NVAX）：以下是你需要了解的信息
诺瓦瓦克斯（Novavax，股票代码NVAX）近期进入Zacks网站最高搜索量股票榜单，相关基本面因素可作为判断其短期走势的核心依据。 过去一个月，诺瓦瓦克斯股...
06-23 22:06
Novavax set for a seventh straight decline
Shares of Novavax (NVAX) fell 2.84% to $8.38 in the afternoon trade on Tuesday, adding to a six-session slide. The stock has fallen around 18% between June 1 and June 8, compared to a 2.56% decline in...
06-10 01:05
诺瓦瓦克斯15分钟图表显示布林带收窄、KDJ指标死叉
诺瓦瓦克斯医药公司（Novavax）15分钟图表近期布林带收窄，2026年6月2日13:30出现KDJ死叉。 布林带收窄是价格波动性降低的迹象，可能是重大价格变...
06-03 01:46
FDA AdCom panel to review and vote on next COVID shots
An advisory panel of the U.S. Food and Drug Administration will meet this week to discuss and vote on the composition of the 2026–2027 formula for COVID shots to be used during the next immunization d...
05-26 23:49
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant
US FDA advisers to weigh updating 2026-27 COVID vaccines to target XFG variant May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG subvariant for the 2026-27 immunization campaign, accordin
05-26 22:52
Transcript: Dyadic International Q1 2026 Earnings Conference Call
Dyadic International (NASDAQ:DYAI) reported first-quarter financial results on ...
05-14 05:54
